Association between Benzodiazepine Use and Dementia: A Meta-Analysis

Area of Science:

• Neuroscience
• Pharmacology
• Epidemiology

Background:

• The link between long-term benzodiazepine use and dementia risk is debated.
• Existing research lacks conclusive evidence, necessitating further investigation.

Purpose of the Study:

• To quantitatively assess the association between benzodiazepine use and dementia risk.
• To explore a potential dose-response relationship in this association.

Main Methods:

• A systematic literature search was conducted across PubMed, Embase, and the Cochrane Library up to August 2014.
• Meta-analysis included six studies (11,891 dementia cases, 45,391 participants) using random-effects models.
• Risk estimates for dementia associated with benzodiazepine use were analyzed.

Main Results:

• Benzodiazepine users showed a significantly increased risk of dementia compared to non-users (RR 1.49, 95% CI 1.30-1.72).
• Recent and past users exhibited similar elevated risks (RR 1.55, 95% CI 1.31-1.83 and RR 1.55, 95% CI 1.17-2.03, respectively).
• A dose-response relationship was identified, with a 22% increased dementia risk for every additional 20 defined daily doses per year.

Conclusions:

• Long-term benzodiazepine use is associated with an increased risk of dementia.
• Findings should be interpreted cautiously due to study limitations and potential reverse causation.
• Further large-scale prospective cohort studies are recommended to validate these results.